Author Correction: Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel‑related ovarian damage in mice

• Adel I. Alalawy,
• Mohamed Sakran,
• Fahad M. Alzuaibr,
• Maeidh A. Alotaibi,
• Mohamed E. El‑Hefnawy,
• Abdulelah Y. Hazazi,
• Saad M. El‑Gendy,
• Esraa A. Aidy,
• Heba Effat,
• Doha F. Ismail,
• Mohamed Hessien

Affiliations

Adel I. Alalawy

Department of Biochemistry, Faculty of Science, University of Tabuk

Mohamed Sakran

Department of Biochemistry, Faculty of Science, University of Tabuk

Fahad M. Alzuaibr

Biology Department, Faculty of Science, Tabuk University

Maeidh A. Alotaibi

King Faisal Medical Complex Laboratory, Ministry of Health

Mohamed E. El‑Hefnawy

Division of Biochemistry, Faculty of Science, Tanta University

Abdulelah Y. Hazazi

Department of Biochemistry, Faculty of Science, University of Tabuk

Saad M. El‑Gendy

Department of Cancer Biology, National Cancer Institute, Cairo University

Esraa A. Aidy

Department of Cancer Biology, National Cancer Institute, Cairo University

Heba Effat

Department of Cancer Biology, National Cancer Institute, Cairo University

Doha F. Ismail

Department of Cancer Biology, National Cancer Institute, Cairo University

Mohamed Hessien

Division of Biochemistry, Faculty of Science, Tanta University